Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-11-14

FDA Approved: ALFUZOSIN HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approved a supplemental application for alfuzosin hydrochloride by Sun Pharmaceutical Industries, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ALFUZOSIN HYDROCHLORIDE (alfuzosin hydrochloride)

Snippet

SUPPL AP for ALFUZOSIN HYDROCHLORIDE (ALFUZOSIN HYDROCHLORIDE)